<DOC>
	<DOCNO>NCT02951975</DOCNO>
	<brief_summary>This observational study evaluate safety , efficacy , characteristic patient , characteristic physicians quality life patient prescribed OZURDEX® treatment non-infectious uveitis posterior segment eye France .</brief_summary>
	<brief_title>Ozurdex® Patients With Non-infectious Uveitis Affecting Posterior Segment Eye</brief_title>
	<detailed_description />
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Patient noninfectious uveitis affect posterior segment eye . Patient reside metropolitan France .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>